| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.086 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.076 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |